Abstract
Triple-negative breast cancer (TNBC) is highly heterogeneous in the stromal and immune microenvironment, genome integrity, oncogenic signatures, and metabolic processes. However, a classification of TNBC by combining these features remains lacking. Here we classified TNBC based on the enrichment levels of 14 pathways related to immune, stromal, oncogenic and metabolic signatures by unsupervised clustering. In three bulk tumor transcriptome datasets and a single cell RNA-Seq (scRNA-seq) dataset, we consistently identified four TNBC subtypes: Imm-E, Str-E, DR-E, and Met-E. Imm-E displayed the strongest immune signatures, the lowest intratumor heterogeneity (ITH), the highest global methylation levels, the lowest tumor purity, and the best prognosis. Str-E showed the strongest stromal signatures and TGF-β signaling. DR-E had the highest DNA repair activity, cell cycle activity, and genomic instability. Met-E demonstrated the strongest hormone metabolism and signaling, the highest ITH, the lowest genomic instability, and the worst prognosis. The subtyping of TNBC provides novel insights into tumor biology and clinical implications for this disease.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
